Bioavailability, Drug Delivery, Manufacturing and Scientist

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Bioavailability

Drug Delivery

Manufacturing

Scientist

Cell-penetrating peptides as a delivery system for oligonucleotides

Drug Discovery World

AUGUST 3, 2022

CDMO in peptides and oligonucleotides manufacturing, Bachem, has started building a new future for oligonucleotides: solving the industry’s main challenges around capacity, sustainability and cost-effectiveness. Ensuring that the CPP can escape this endosomal compartment is crucial for its bioavailability and bioactivity properties.

Bioavailability

Bioavailability In-Vivo RNA In-Vitro

The Power of Lipids: Enhancing Drug Delivery with Nanoparticles

Roots Analysis

MAY 21, 2024

Over the last decade, one of the major challenges faced by pharmaceutical companies across the globe is low drug solubility. In fact, it has been observed that around 40% of the pharmaceutical drugs approved by regulatory organizations exhibit poor bioavailability / solubility.

Drug Delivery

Drug Delivery Drugs Gene Therapy Bioavailability

Clinical Research Informer

Cell-penetrating peptides as a delivery system for oligonucleotides

The Power of Lipids: Enhancing Drug Delivery with Nanoparticles

Stay Connected